# A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

> **NCT06979375** · PHASE2 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 200 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** CDR132L
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06979375
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2027-05-16
- **Final completion:** 2028-01-23
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06979375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06979375, "A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06979375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*